Abbott Diagnostics Educational Program

The International Liver Congress™by EASL
Abbott Satellite Symposium
April 15, 2010

Quantitative HBsAg for HBV therapy monitoring: An old serum marker rediscovered
HBV treatment is a challenge for patients and healthcare professionals around the world. During the Abbott Satellite Symposium at the EASL 2010, Lab professionals and clinicians were able to connect their knowledge and discuss the importance of the quantitative HBsAg during HBV treatment monitoring. Because every result has a face, the laboratory expertise is crucial for the clinical practices. Learn more here:

Presentations

HBsAg quantitation: Why and how?
Prof. Wolfram Gerlich, Giessen, Germany   [373MB]

Follow-up of HBsAg concentration as marker of long term resolution
Prof. Jörg Petersen, Hamburg, Germany   [300MB]